Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -73.44x is 44% above its 4-year average of -130.88x, near the high end of its 4-year range (-9693.67x–-15.20x).
5.97% below its 12-month average of -69.30x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -15.20x.
INTEREST COVERAGE RATIO
-73.44x
INTEREST COVERAGE RATIO AVG TTM
-69.30x
INTEREST COVERAGE RATIO AVG 3Y
-78.51x
INTEREST COVERAGE RATIO AVG 5Y
-130.88x
INTEREST COVERAGE RATIO AVG 10Y
-91.49x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-5.97%
CURRENT VS 3Y AVG
+6.46%
CURRENT VS 5Y AVG
+43.89%
CURRENT VS 10Y AVG
+19.73%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-1052.00%
vs the sector median at left
Viridian Therapeutics, Inc.
Market Cap
$2.07B
Interest Coverage Ratio
-73.44x
TTM Avg
-69.30x
3Y Avg
-78.51x
5Y Avg
-130.88x
Market Cap
$2.07B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.03B
Interest Coverage Ratio
-0.33x
TTM Avg
467.98x
3Y Avg
502.49x
5Y Avg
502.49x
Market Cap
$2.04B
Interest Coverage Ratio
4.32x
TTM Avg
4.32x
3Y Avg
4.32x
5Y Avg
4.32x
Market Cap
$2.08B
Interest Coverage Ratio
7.10x
TTM Avg
7.23x
3Y Avg
7.23x
5Y Avg
136.60x
Market Cap
$2.08B
Interest Coverage Ratio
-41.89x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.04B
Interest Coverage Ratio
N/A
TTM Avg
166.84x
3Y Avg
166.84x
5Y Avg
166.84x
Market Cap
$2.04B
Interest Coverage Ratio
-3.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viridian Therapeutics, Inc. (VRDN) | $2.07B | -73.44x | -69.30x | -78.51x | -130.88x |
| Alvotech (ALVO)vs › | $2.07B | 0.52x | 0.48x | 0.48x | 0.48x |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.07B | N/A | N/A | N/A | N/A |
| Fortrea Holdings Inc. (FTRE)vs › | $2.03B | -0.33x | 467.98x | 502.49x | 502.49x |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.04B | 4.32x | 4.32x | 4.32x | 4.32x |
| Vericel Corporation (VCEL)vs › | $2.08B | 7.10x | 7.23x | 7.23x | 136.60x |
| Vera Therapeutics, Inc. (VERA)vs › | $2.08B | -41.89x | N/A | N/A | N/A |
| Progyny, Inc. (PGNY)vs › | $2.04B | N/A | 166.84x | 166.84x | 166.84x |
| UroGen Pharma Ltd. (URGN)vs › | $2.04B | -3.69x | N/A | N/A | N/A |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.03B | 24.23x | 24.23x | 24.23x | 24.23x |
Interest Coverage
-73.4x
Debt/Equity
0.37
Current Ratio
16.95
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -15.20x |
| 2026-03-31 | -33.56x |
| 2025-12-31 | -18.58x |
| 2025-09-30 | -71.45x |
| 2025-06-30 | -207.72x |
| 2025-03-31 | -160.18x |
| 2024-12-31 | -101.95x |
| 2024-09-30 | -83.15x |
| 2024-06-30 | -120.92x |
| 2024-03-31 | -95.22x |
| 2023-12-31 | -78.03x |
| 2023-09-30 | -85.37x |
| 2023-06-30 | -357.08x |
| 2023-03-31 | -439.23x |
| 2022-12-31 | -292.06x |
| 2022-09-30 | -181.62x |
| 2022-06-30 | -191.97x |
| 2021-12-31 | -9693.67x |
| 2020-12-31 | -503.32x |
| 2020-09-30 | -58.17x |
| 2020-06-30 | -67.81x |
| 2020-03-31 | -56.72x |
| 2019-12-31 | -59.24x |
| 2019-09-30 | -55.05x |
| 2019-06-30 | -39.05x |
| 2019-03-31 | -50.59x |
| 2018-12-31 | -45.85x |
| 2018-09-30 | -41.22x |
| 2018-06-30 | -41.41x |
| 2018-03-31 | -22.10x |
| 2017-12-31 | -33.44x |
| 2017-09-30 | -101.53x |
| 2017-06-30 | -114.84x |
| 2017-03-31 | -97.73x |
| 2016-12-31 | -210.50x |
| 2016-09-30 | -78.96x |
| 2016-06-30 | -108.00x |
| 2016-03-31 | -118.91x |
| 2015-12-31 | -128.57x |
| 2015-09-30 | -130.33x |
| 2015-06-30 | -34.58x |
| 2015-03-31 | -118.73x |
| 2014-12-31 | -1025.86x |
| 2014-09-30 | -393.13x |
| 2014-06-30 | -5.89x |
| 2014-03-31 | -0.31x |
| 2013-12-31 | 0.56x |
| 2013-09-30 | -0.55x |
| 2013-06-30 | -0.13x |
| 2013-03-31 | -0.17x |
